Praziquantel and Albendazole
PreclinicalSmall molecule
Praziquantel and Albendazole is one of 2 small molecule programs targeting Treatment Outcome. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
1
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
1 competitor in Treatment Outcome
#DrugCompanyPhaseTrials
1Dostinex
PfizerPreclinical
Praziquantel and Albendazole
CCatholic University of Health and Allied Sciences
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Treatment Outcome1 trial
A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes
Unknown status·—·N/A·NCT01541631·2,000 enrolled
Sources
References
- [1]
- [2]
- [3]
- [4]
Details